Invyncible Tirzepatide Review: Cost, Named Pharmacies & Honest Verdict (2026)

Invyncible publishes the price of every tirzepatide program on its open site — no account, no intake, no quiz — and names all six compounding pharmacies it works with. Every fact here comes from the company's own published pages.

What Invyncible is

Invyncible is a Florida-based telehealth platform offering compounded semaglutide and tirzepatide programs, brand-name Wegovy and Zepbound, and a range of other injectable and oral programs. Its corporate parent is disclosed — Nationwide Telemedicine, LLC — with a published physical address in St. Petersburg, FL, and a working, domain-specific LegitScript verification link.

What Invyncible tirzepatide costs

The standard compounded tirzepatide program is $210 for four weeks at the starter dose — 2.5 mg weekly, a 10 mg vial — shown against a struck-through $300 list price. The cheapest tirzepatide in the catalog is the glycine + B12 formulation at $180 for four weeks; a B12 version runs $260, and a two-month B3 program is $318.75.

That entry figure is a starting price, not a flat rate. The same standard program costs $280 at 5 mg weekly and $402.50 at 12.5 mg weekly, and Invyncible's own FAQ confirms that cost can rise as the dose increases. Brand Zepbound is stocked separately at $1,540, against a $2,200 list price.

One thing to read past: every item in the catalog carries a struck-through higher figure, and the category page invites you to call for a further discount. A discount that applies to everything permanently is a price, not a saving — treat the left-hand number as the real one.

The brand-vs-compounded question

Invyncible labels this plainly, which many competitors do not: each program is tagged Standard Formula, Includes Glycine + B12, Oral Option or FDA-Approved Brand on the catalog itself, so compounded and brand, injection and oral are separated before you click.

What is not stated anywhere is the 503A vs. 503B designation of the pharmacy that fills it. The company names six — Empower, Strive, Center City, Partell, PerfectRx and MFV — with street addresses and phone numbers, and lets a patient choose which one receives the prescription, name one outside the network, or request a copy to fill anywhere. It simply never says which of them compounds patient-by-patient and which produces in registered batches.

Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

A licensed provider reviews every intake before a prescription decision, and the FAQ says a live consultation may be required depending on the treatment, your history and your state's telemedicine rules. Payment is authorized at checkout but only finalized if a provider approves the prescription, and refills are not automatic — you request them — so there is no auto-billed subscription sitting underneath the price. Support is US-based phone, email and website live chat with the number in the header of every page, though weekday business hours only, Monday to Friday, 9am to 5pm EST.

Coverage is 46 states plus Washington, D.C., with California, Mississippi, New Mexico and Oregon named as the four not served. Tirzepatide specifically is narrower than that headline: its program page also excludes Alabama, Arkansas, Hawaii, Kansas, Massachusetts, Michigan and Minnesota.

The remaining trade-offs are money you meet later. Shipping is charged separately at checkout and the amount is published nowhere, and because tirzepatide needs refrigeration the only option available to you is overnight cold. Allow 5-7 business days of provider and pharmacy processing before anything ships. As with any GLP-1 program, confirm the price of your next dose step before committing; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

Invyncible does the two things this site most often finds missing: it publishes its prices in the open, and it names the pharmacies that fill them. Set against that, the entry figure is the smallest vial and climbs at every dose step, the permanent strike-through pricing is theater rather than a saving, and no 503A or 503B designation appears anywhere on the site. Compare it against CoreAge Rx or BiltRx, and see our best tirzepatide providers ranking for the full field.